Çağatay ÖNCEL, Buket OFLAZOĞLU, Hulki FORTA, Nihal YÜCEL, Nezaket EREN

Plasma cortisol levels in migraineurs between attacks

Migrende hipotalamo-pituiter-adrenal aksın rolünü araştırmak için başağrısı atakları arasında migrenlilerde plazma kortizol düzeyini araştırdık. 25 migrenli ve 24 sağlıklı kontrol grubundan saat 8.30-9.30 arasında alınan kan örneklerinde bakılan kortizol düzeylerinde gruplar arasında istatistiksel anlamlılık bulunmadı.

Anahtar Kelimeler:

Hidrokortizon, Migren bozuklukları, Baş ağrısı

Migrenlilerde ataklar arasında plazma kortizol düzeyleri

We have studied the plasma cortisol level between attacks in order to investigate the role of hypothalamic-pituitary-adrenal axis in migraine patients. We have not found any statistically significance between plasma cortisol levels of patients and control group, after taking the blood of 25 patients and 24 healthy controls between 8.30-9.30 am.

Keywords:

Hydrocortisone, Migraine Disorders, Headache,

PDF

___

Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ:Brainstem activation spesific to migraine headache .The Lancet 2001; 357: 1016-1017.
Grazzi L, Bussone G: Effect of biofeedback treatment on sympathetic function in common migraine and tension-type headache.Cephalalgia 1993; 13: 197-200.
Grazzi L, Bussone G: Effect of biofeedback treatment on sympathetic function in common migraine and tension-type headache.Cephalalgia 1993;13:197-200.
Hilten van JJ, Ferrari MD, Van der Meer JVVM, Gijsman HJ, Looij BJ:Plasma interleukin-1, tumour necrosis factor and hypothalamicpituitary-adrenal axis responses during migraine attacks.Cephalalgia 1991; 11: 65-67.
Leone M, Biffi M: Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension type headache. Cephalalgia 1994; 14:139-142.
May A, Bahra A, Büchel C, Frackowiak R.S.J, Goadsby P.J:Hypothalamic activation in cluster headache attacks. Lancet 1998;352: 275-278.
May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ: PET and MRA findings in cluster headache and MRA in experimental pain. Neurol 2000; 55: 1328-1335.
Nappi RE, Sances G, Brundu B, Ghiotto N, Detaddei S, Biancardi C,Polatti F, Nappi G: Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology. 2003 Jul; 78(1): 52-60.
Olesen J, Tfelt-Hansen P, Welch KMA: The Headaches. 2nded.Philadelphia, Pa: Lippincott Williams and Wilkins; 2000. pp 10,313-317, 691, 705.
Patacchioli FR, Monnazzi P, Simeoni S, De Filippis S, Salvatori E,Coloprisco G, Martelletti P: Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraine. J Headache Pain. 2006 Apr; 7(2): 90-4. Epub 2006 Mar 31.
Peres MFP, Sanchez del Rio M, Seabra MLV, Tufik S et al:Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 2001;71:747-751.
Peroutka SJ: Migraine: a chronic sympathetic nervous system disorder.Headache. 2004 Jan; 44(1): 53-64.
Rainero I, Ferrero M, Rubino E, Valfre W, Pellegrino M, Arvat E,Giordano R, Ghigo E, Limone P, Pinessi L: Endocrine function isaltered in chronic migraine patients with medication-overuse.Headache. 2006 Apr; 46(4): 597-603.
Shechter A, Stewart WF, Silberstein SD, Lipton RB: Migraine and autonomic nervous system function: a population-based, casecontrol study. Neurology. 2002 Feb 12; 58(3): 422-427.
Silberstein SD, Saper JR: Migraine: Diagnosis and treatment in:Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff’s Headache and another head pain. New York: Oxford University Press, 2001. pp.128-130.